Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer ... - Sacramento Bee

Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer ... Sacramento Bee "We believe ERG testing by IHC and ISH will play an important role in novel diagnostic, prognostic, and predictive tests for prostate cancer," says Mara G. Aspinall, President of Ventana Medical Systems, Inc. "This license gives us a unique position ... and more »

Oncomine contributes to integrative genomic analysis of lethal castration ... - Sacramento Bee

Oncomine contributes to integrative genomic analysis of lethal castration ... Sacramento Bee Integrated analysis of copy number and mutation data identified loss of CHD1, a chromatin-modifying enzyme, as a key genetic event in ETS-negative prostate cancer. With Oncomine, the team was able to rapidly validate this observation across 13 ... and more »